Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers

NCT00006457 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00006457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2000
Completion date
April 30, 2004
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer